INBX (Inhibrx Biosciences) Accounts Payable: $8.76 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

INBX Inhibrx Biosciences Inc INBX
6 GF Score
Price $98.67
! 5 Warning Signs
View Full Analysis

What is Inhibrx Biosciences Accounts Payable?

Inhibrx Biosciences INBX +6.47% 6 Accounts Payable is $8.76 Mil as of Mar. 2026. GuruFocus rates INBX with a GF Score™ of 6/100. The stock has 5 warning signs investors should review.

Inhibrx Biosciences's Accounts Payable for the quarter that ended in Mar. 2026 was $8.76 Mil.

Inhibrx Biosciences's quarterly Accounts Payable declined from Sep. 2025 ($6.77 Mil) to Dec. 2025 ($5.94 Mil) but then increased from Dec. 2025 ($5.94 Mil) to Mar. 2026 ($8.76 Mil).

Inhibrx Biosciences's annual Accounts Payable declined from Dec. 2023 ($10.95 Mil) to Dec. 2024 ($9.25 Mil) and declined from Dec. 2024 ($9.25 Mil) to Dec. 2025 ($5.94 Mil).

Inhibrx Biosciences Accounts Payable Related Terms

Inhibrx Biosciences Accounts Payable Historical Data

* Premium members only.

The historical data trend for Inhibrx Biosciences's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inhibrx Biosciences Accounts Payable Chart

Inhibrx Biosciences Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Accounts Payable
4.34 10.95 9.25 5.94

Inhibrx Biosciences Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.89 8.29 6.77 5.94 8.76
INBX
6GF Score
Inhibrx Biosciences Inc INBX
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inhibrx Biosciences Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $8.76 Mil mean?
Inhibrx Biosciences (INBX) has a Accounts Payable of $8.76 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Inhibrx Biosciences and its competitors.
Is Inhibrx Biosciences' Accounts Payable too high?
Inhibrx Biosciences' current Accounts Payable is $8.76 Mil. Overall, Inhibrx Biosciences has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Inhibrx Biosciences' Accounts Payable compare to JBIO and NVAX?
Inhibrx Biosciences' Accounts Payable of $8.76 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Inhibrx Biosciences and its competitors. Inhibrx Biosciences's current Accounts Payable is $8.76 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inhibrx Biosciences stock overvalued right now?
Inhibrx Biosciences (INBX) has a current Accounts Payable of $8.76 Mil. The current Accounts Payable is $8.76 Mil. Inhibrx Biosciences' overall GF Score™ is 6/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Inhibrx Biosciences (INBX), the current Accounts Payable is $8.76 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Inhibrx Biosciences Business Description

Address 11025 N. Torrey Pines Road, Suite 140, La Jolla, CA, USA, 92037
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
6GF Score

Get the complete analysis for INBX

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$98.67
Price